相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Nomacopan for Treatment of Bullous Pemphigoid A Phase 2a Nonrandomized Controlled Trial
Christian D. Sadik et al.
JAMA DERMATOLOGY (2022)
A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets
Mohsen Afarideh et al.
JOURNAL OF CLINICAL MEDICINE (2022)
The relevance of complement in pemphigoid diseases: A critical appraisal
Cristian Papara et al.
FRONTIERS IN IMMUNOLOGY (2022)
Diagnostic Utility of C4d by Direct Immunofluorescence in Bullous Pemphigoid
Jeffrey Damman et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2021)
Blockade of complement activation in bullous pemphigoid by using recombinant CD55-CD46 fusion protein
Pei Qiao et al.
CHINESE MEDICAL JOURNAL (2021)
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Peter Hillmen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Recent progresses and perspectives in autoimmune bullous diseases
Christian D. Sadik et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid
Patricia Colchete Freire et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review
Gareth Edwards et al.
FRONTIERS IN IMMUNOLOGY (2019)
Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid
Joost M. Meijer et al.
JAMA DERMATOLOGY (2019)
Extracting the barbs from complement assays: Identification and optimisation of a safe substitute for traditional buffers
Wioleta M. Zelek et al.
IMMUNOBIOLOGY (2018)
The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies
Anika Kasprick et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases
Joost M. Meijer et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice
Sidonia Mihai et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2
Christian M. Karsten et al.
FRONTIERS IN IMMUNOLOGY (2018)
Complement in bullous pemphigoid: results from a large observational study
T. R. Romeijn et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications
Marta Subias Hidalgo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Complement Fixation Test: An Update of an Old Method for Diagnosis of Bullous Pemphigoid
Jana Jankaskova et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C
Hiroaki Iwata et al.
LABORATORY INVESTIGATION (2016)
A Novel Antibody against Human Factor B that Blocks Formation of the C3bB Proconvertase and Inhibits Complement Activation in Disease Models
Marta Subias et al.
JOURNAL OF IMMUNOLOGY (2014)
Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation without Complement Activation
Hideyuki Ujiie et al.
JOURNAL OF IMMUNOLOGY (2014)
Lessons learned from mice deficient in lectin complement pathway molecules
Ninette Genster et al.
MOLECULAR IMMUNOLOGY (2014)
Bullous Pemphigoid IgG Induces BP180 Internalization via a Macropinocytic Pathway
Sho Hiroyasu et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Antibodies to Pathogenic Epitopes or Type XVII Collagen Cause Skin Fragility in a Complement-Dependent and -Independent Manner
Ken Natsuga et al.
JOURNAL OF IMMUNOLOGY (2012)
The C5a Receptor on Mast Cells Is Critical for the Autoimmune Skin-blistering Disease Bullous Pemphigoid
Lisa Heimbach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Systemic Complement Activation in Deceased Donors Is Associated With Acute Rejection After Renal Transplantation in the Recipient
Jeffrey Damman et al.
TRANSPLANTATION (2011)
Risk Factors for Relapse in Patients With Bullous Pemphigoid in Clinical Remission
Philippe Bernard et al.
ARCHIVES OF DERMATOLOGY (2009)
C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid
Wells Chandler et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180-kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell Attachment
Hiroaki Iwata et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection
Kazunori Murata et al.
Transplantation Reviews (2009)
Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
Zhi Liu et al.
JOURNAL OF AUTOIMMUNITY (2008)
The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease
Cynthia M. Magro et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Role of different pathways of the complement cascade in experimental bullous pemphigoid
Kelly C. Nelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells
AJ Nauta et al.
JOURNAL OF IMMUNOLOGY (2004)
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid
RY Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
